tirzepatide isn't working anymore a weight drug. It's an inflammation drug that happens to help with weight. That's why it's quietly changing the MCAS conversation. Dual GLP-1 / GIP agonist. GLP-1 slows gut motility Tirzepatide dosing chart I"ll share
Description
Dual-Pathway Action Targets both GLP-1 and GIP receptors simultaneously for more comprehensive appetite control and metabolic support than single-pathway medications

Discard the pen if it has been frozen

Patients with longstanding type 2 diabetes often have substantial beta-cell loss, which can vary among individuals, potentially limiting their capacity to increase insulin secretion even with dual GIP/GLP-1 receptor stimulation

Our two locations in The Heights and Vintage Park are staffed by trained clinicians operating under physician guidance, ensuring safe, effective, and personalized weight loss protocols
At the same time, symptoms affecting the skin can sometimes be dermatological reactions , meaning reactions involving the skin itself